Ending market exclusivity for statins saves US $12 billion and individuals nearly $1,000 annually

Prescription drug costs represent nearly 10 percent of total health care expenses for Americans, pushing the issue to the forefront of national health care policy conversations. With rising costs an ongoing concern, a study released today in JAMA Network Open, published by the American Medical Association, shows the impact that introducing generic medications to the marketplace can have on bringing down prices.

This post was originally published on this site

KeyLegal.ca - Consult a Lawyer Online in a variety of legal subjects